Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Pharmacotherapy|March 1, 1984
Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agentJ A SinkuleJournal of Chromatography|May 13, 1983
High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosidesJ A Sinkule, W E EvansJournal of Pharmaceutical Sciences|February 1, 1984
High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detectionJ A Sinkule, W E EvansTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methodsJ A Sinkule, S T Rosen, J A RadosevichClinical Pharmacology and Therapeutics|January 1, 1987
Interpatient and intrapatient variability in vinblastine pharmacokineticsM J Ratain, N J Vogelzang, J A SinkuleJournal of Chromatography|November 12, 1982
Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detectionC Akpofure, C A Riley, J A Sinkule, et al.Cancer Research|July 1, 1984
Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumorsJ A Sinkule, P Hutson, F A Hayes, et al.Cancer Research|December 1, 1983
Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblastsL W Dow, J A Sinkule, A T Look, et al.Cancer Research|April 1, 1987
Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancerC L Bennett, J A Sinkule, R L Schilsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1984
Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemiaJ Ochs, J A Sinkule, M K Danks, et al.Pageof 2